previous compound ID: 1430 next compound
InChIKey: MUMGGOZAMZWBJJ-DYKIIFRCSA-N
SMILES: C[C@]12CC[C@H]3[C@H]([C@@H]1CC[C@@H]2O)CCC4=CC(=O)CC[C@]34C

biological descriptors:

CFTR relevance: unspecified

Category:
Influence on CFTR function unknown
Order of interaction unknown
subcellular compartment unknown

reference list:

ReferenceID: 53
"DY Thomas" "GW Carlile" "J Goepp" "D Rotin" "E Matthes" "B Kus" "SD Macknight" "R Robert" "JW Hanrahan" "J Liao"

chemical graph of compound 1430





CID is 6013
synonyms found at PubChem are:
testosterone, 58-22-0, Testosteron, Androderm, Mertestate, Sustanon, Testoderm, Virosterone, Androlin, Oreton, Testim, AndroGel, Synandrol F, Testosteroid, Andronaq, Andropatch, Andrusol, Homosteron, Homosterone, Malerone, Orquisteron, Perandren, Primotest, Primoteston, Sustanone, Testandrone, Testobase, Testogel, Testopropon, Testoviron, Testrone, trans-Testosterone, Relibra, Teslen, Testryl, Testiculosterone, Cristerona T, Cristerone T, Testoviron T, Testosteronum, Testostosterone, Neotestis, Testosterona, Testoviron Schering, Geno-cristaux gremy, LibiGel, 17beta-Hydroxyandrost-4-en-3-one, Neo-Hombreol F, Oreton-F, Testoject-50, Striant, Testolin, Andro 100, Testosterone hydrate, Percutacrine androgenique, Neo-testis, Sustason 250, Testoderm Tts, beta testosterone, Malestrone (amps), Intrinsa, Virormone, Malogen, aquaspension injection, Testosteronum [INN-Latin], Testosterona [INN-Spanish], Testro AQ, Androst-4-en-17beta-ol-3-one, Testopel Pellets, Oreton F, CDB 111C, Testosterone and its esters, 17beta-Hydroxy-4-androsten-3-one, 7-beta-Hydroxyandrost-4-en-3-one, COL 1621, delta4-Androsten-17beta-ol-3-one, 17beta-Hydroxyandrost-4-ene-3-one, 17-beta-Hydroxyandrost-4-en-3-one, Halotensin, Androsorb, Testaqua, 4-Androsten-17beta-ol-3-one, CP 601B, T-Cypionate, Testosterone [INN:BAN], Malogen in Oil, Virilon IM, 17-Hydroxy-(17beta)-androst-4-en-3-one, 17beta-Hydroxy-delta(sup4)-androsten-3-one, delta(sup 4)-Androsten-17(beta)-ol-3-one, Testrin-P.A, 17-Hydroxy-(17-beta)-androst-4-en-3-one, Androderm (TN), UNII-3XMK78S47O, Androgel (TN), Andronate 100, Andronate 200, Andropository 200, CCRIS 574, Striant (TN), Testamone 100, 17-beta-Hydroxy-delta(sup 4)-androsten-3-one, AA 2500, Androst-4-en-3-one, 17beta-hydroxy-, Testim (TN), Androst-4-en-3-one, 17-hydroxy-, (17beta)-, Everone 200, Androst-4-en-3-one, 17-beta-hydroxy-, Andryl 200, CHEBI:17347, HSDB 3398, Scheinpharm Testone-Cyp, Testred Cypionate 200, NSC 9700, EINECS 200-370-5, Testosterone (JAN/USP), (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one, (17beta)-17-Hydroxyandrost-4-en-3-one, 3XMK78S47O, Testosterone [Androgenic steroids, anabolic], 4-androstene-17beta-ol-3-one, 17b-hydroxy-4-androsten-3-one, delta4-androsten-17b-ol-3-one, MUMGGOZAMZWBJJ-DYKIIFRCSA-N, Androst-4-en-3-one, 17-hydroxy-, (17-beta)-, CMC_13449, Androst-4-en-3-one, 17-hydroxy-, (17b)-, Fortesta, Nasobol, Natesto, Vogelxo, Axiron, Tefina, CompleoTRT, Androgel 1%, 17.beta.-Testosterone, SMR000058344, Bio-T-Gel, Androgel 1.62%, Androst-4-en-3-one, 17-hydroxy-, (17.beta.)-, Androst-4-en-3-on-17B-ol, CHEMBL386630, component of Duogen (Salt/Mix), component of Tostrex (Salt/Mix), component of Di-Met (Salt/Mix), component of Intrinsa (Salt/Mix), 4-Androsten-17.beta.-ol-3-one, 4-Androsten-3-one-17.beta.-ol, Tlando, component of Di-Genik (Salt/Mix), 4-Androsten-3-one, 17b-hydroxy-, Testosterone [USP:INN:BAN], component of Mal-O-Fem (Salt/Mix), LPCN 1021, Testosterone, 1, 3kdm, 17-.beta.-Hydroxyandrost-4-en-3-one, NCGC00091018-01, CPD000058344, 17beta-testosterone, Testosterone solution, Axiron (TN), mpp10, 17.beta.-Hydroxy-.DELTA.4-androsten-3-one, Androderm, Delatestryl, 17-Hydroxyandrost-4-en-3-one, (17.beta.)-, Testosterone, >=98%, DSSTox_CID_2371, D06XMU, Epitope ID:135865, EC 200-370-5, AC1L1LM0, SCHEMBL8452, 4-androsten-17-ol-3-one, DSSTox_RID_76563, DSSTox_GSID_22371, MLS000563091, MLS001032098, MLS001306401, MLS001424262, MLS002174283, BIDD:ER0555, BDBM8885, GTPL2858, 17-Hydroxy-4-androsten-3-one, DTXSID8022371, 17beta-hydroxy-4-androsten-3one, Testosterone, cell culture tested, 1i37, HMS2052N11, HMS2272B03, HMS2272P03, (8R,9S,10R,13S,14S,17S)-17-Hydroxy-10,13-dimethyl-6,7,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3(2H)-one, 17beta-Hydroxy-3-oxo-4-androstene, Tox21_200689, HY-15554A, LMST02020002, RB3046, AKOS015894897, ZINC118912393, CCG-101189, CS-1415, DB00624, MCULE-1294118086, NC00439, RP29985, CAS-58-22-0, Testosterone 1.0 mg/ml in Acetonitrile, (17?)-17-Hydroxyandrost-4-en-3-one, NCGC00258243-01, AC-14899, AN-23597, BC208298, SC-15109, SMR001261453, Testosterone, purum, >=99.0% (HPLC), LS-148813, Testosterone 100 microg/mL in Acetonitrile, BIM-0061761.0001, C00535, D00075, S00309, W-5033, AB00973630-03, Testosterone, VETRANAL(TM), analytical standard, 003T654, Androst-4-en-3-one, 17-hydroxy, (17.beta.)-, C-18145, Q-101251, B5DEE83F-632B-48A1-A0ED-A51E7F13DF2E, Testosterone, European Pharmacopoeia (EP) Reference Standard, (8alpha,10alpha,13alpha,14beta,17alpha)-17-hydroxyandrost-4-en-3-one, Testosterone solution, 1.0 mg/mL in 1,2-dimethoxyethane, drug standard, Testosterone; 4-Androsten-17?-ol-3-one; 17?-Hydroxy-4-androsten-3-one, Testosterone for impurity D identification, European Pharmacopoeia (EP) Reference Standard, Testosterone for system suitability, European Pharmacopoeia (EP) Reference Standard, (1S,2R,10R,11S,14S,15S)-14-hydroxy-2,15-dimethyltetracyclo[8.7.0.0;{2,7}.0;{11,15}]heptadec-6-en-5-one, (8R,9S,10R,13S,14S,17S)-17-hydroxy-10,13-dimethyl-1,2,6,7,8,9,10,11,12,13,14,15,16,17-tetradecahydro-3H-cyclopenta[a]phenanthren-3-one, 1050678-68-6, Testosterone solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material